Tag: fact cell destruction

Syneron receives US FDA clearance to market UltraShape for fat cell destruction

Apr 14, 2014 | 0 |

Syneron Medical Ltd. (NASDAQ: ELOS) has announced that it has received the United States Food and Drug Administration (FDA) 510(k) clearance to...

Start date: July 7, 2022 - End date: July 10, 2022

Start date: November 4, 2022 - End date: November 5, 2022

Location: Monte Carlo, Monaco

Start date: November 5, 2022 - End date: November 6, 2022

Location: Tokyo, Japan

Start date: November 17, 2022 - End date: November 19, 2022

Location: Medellin, Colombia

Start date: November 24, 2022 - End date: November 26, 2022

Location: Bangkok, Thailand